HomeQuestion

How do you interpret the Phase 1 results of the Enzalutamide Delivery Implant (Enolen) for low- to intermediate-risk localized prostate cancer?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you manage recurrent asymptomatic transaminitis from VEGF TKI in a patient renal cell carcinoma who needs drug to control disease?

What time frame, number of PSAs, and calculator do you use for calculating PSA doubling times?

What is the optimal modality and radiology protocol you prefer to evaluate/stage upper urinary tract tumors?

For patients with high-volume hormone-sensitive prostate cancer, would you consider shortening the docetaxel course to 4 cycles to facilitate better tolerance?

If approved, how will you choose between Disitamab Vedotin/Toripalimib (DV+T) and EV+Pembro (EV-303), in those patients with HER2+ mUC?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.